Antibiotics after breast cancer linked to poorer survival, study finds

by Krista Conger,Stanford University Medical CenterLandmarking analysis to evaluate the impact of antimicrobial exposure on survival over time on N = 772 independent patients. Data were presente

Updated on: January 23,2024

Antibiotics after breast cancer linked to poorer survival, study finds

by Krista Conger,Stanford University Medical CenterLandmarking analysis to evaluate the impact of antimicrobial exposure on survival over time on N = 772 independent patients. Data were presente

Updated on:January 23,2024

2023 cisplatin shortage tied to use of alternatives for head, neck cancer

by Lori SolomonThe 2023 cisplatin shortage led to a shift in utilization to alternative therapies for head and neck cancer (HNC), resulting in significant cost increases, according to a study presente

Updated on: October 18,2024

2023 cisplatin shortage tied to use of alternatives for head, neck cancer

by Lori SolomonThe 2023 cisplatin shortage led to a shift in utilization to alternative therapies for head and neck cancer (HNC), resulting in significant cost increases, according to a study presente

Updated on:October 18,2024

Liquid biopsy predicts early disease progression, potential survival in patients with advanced breast cancer

by Johns Hopkins UniversityCredit: Unsplash/CC0 Public DomainA novel, automated liquid biopsy test in development by researchers at the Johns Hopkins Kimmel Cancer Center can be used to predict e

Updated on: February 20,2024

Liquid biopsy predicts early disease progression, potential survival in patients with advanced breast cancer

by Johns Hopkins UniversityCredit: Unsplash/CC0 Public DomainA novel, automated liquid biopsy test in development by researchers at the Johns Hopkins Kimmel Cancer Center can be used to predict e

Updated on:February 20,2024

Blocking inflammatory pathway key to preventing brain metastasis from melanoma

by Tel Aviv UniversityMelanoma. Credit: Wikimedia Commons/National Cancer InstituteBrain metastases are among the deadliest tumor metastases, with a median survival period of less than one year,

Updated on: April 01,2024

Blocking inflammatory pathway key to preventing brain metastasis from melanoma

by Tel Aviv UniversityMelanoma. Credit: Wikimedia Commons/National Cancer InstituteBrain metastases are among the deadliest tumor metastases, with a median survival period of less than one year,

Updated on:April 01,2024

New genetic testing pathways could ensure patients get personalized BRCA-linked cancer treatments

byInstitute of Cancer ResearchThe BRCA-DIRECT Pathway. Credit:British Journal of Cancer(2024). DOI: 10.1038/s41416-024-02832-2Scientists have developed a new clinical pathway for tes

Updated on: October 24,2024

New genetic testing pathways could ensure patients get personalized BRCA-linked cancer treatments

byInstitute of Cancer ResearchThe BRCA-DIRECT Pathway. Credit:British Journal of Cancer(2024). DOI: 10.1038/s41416-024-02832-2Scientists have developed a new clinical pathway for tes

Updated on:October 24,2024

Genetic causes of tumors in salivary glands

by University of Erlangen-NurembergCredit: CC0 Public DomainAcinic cell carcinoma is the third most common malignant form of salivary gland cancer. These tumours are similar to normal salivary gl

Updated on: March 09,2024

Genetic causes of tumors in salivary glands

by University of Erlangen-NurembergCredit: CC0 Public DomainAcinic cell carcinoma is the third most common malignant form of salivary gland cancer. These tumours are similar to normal salivary gl

Updated on:March 09,2024

AI-guided personalized drug combinations to treat relapsed lymphoma

byNational University of SingaporeAsst Prof Anand Jeyasekharan (left) and Assoc Prof Edward Chow (right) from the Cancer Science Institute of Singapore at NUS are pioneering the application of Q

Updated on: January 02,2024

AI-guided personalized drug combinations to treat relapsed lymphoma

byNational University of SingaporeAsst Prof Anand Jeyasekharan (left) and Assoc Prof Edward Chow (right) from the Cancer Science Institute of Singapore at NUS are pioneering the application of Q

Updated on:January 02,2024

Study reveals insights into DDX41 protein's role in blood cancer pathogenesis

by JooHyeon Heo,Ulsan National Institute of Science and TechnologyA schematic image showing the impact of DDX41 mutations on MDS patients. Credit: Won Chan Hwang et al/Ulsan National Institute o

Updated on: April 28,2024

Study reveals insights into DDX41 protein's role in blood cancer pathogenesis

by JooHyeon Heo,Ulsan National Institute of Science and TechnologyA schematic image showing the impact of DDX41 mutations on MDS patients. Credit: Won Chan Hwang et al/Ulsan National Institute o

Updated on:April 28,2024

BRAF inhibitor shows promising results in pediatric patients with low-grade glioma

by American Association for Cancer ResearchGlioma of the left parietal lobe. CT scan with contrast enhancement. Credit: Mikhail Kalinin/CC BY-SA 3.0Dabrafenib (Tafinlar), a BRAF inhibitor approve

Updated on: March 30,2024

BRAF inhibitor shows promising results in pediatric patients with low-grade glioma

by American Association for Cancer ResearchGlioma of the left parietal lobe. CT scan with contrast enhancement. Credit: Mikhail Kalinin/CC BY-SA 3.0Dabrafenib (Tafinlar), a BRAF inhibitor approve

Updated on:March 30,2024

Opportunistic colonizers: Selectively targeting tumor cells with bacteria

by TranSpreadC@ECN-PL delivers CXB to tumor cells via liposomes anchored to the cell surface and promotes immune cell recruitment to the tumor. The self-lysis circuit ensures that C@ECN-PL does not ac

Updated on: July 08,2024

Opportunistic colonizers: Selectively targeting tumor cells with bacteria

by TranSpreadC@ECN-PL delivers CXB to tumor cells via liposomes anchored to the cell surface and promotes immune cell recruitment to the tumor. The self-lysis circuit ensures that C@ECN-PL does not ac

Updated on:July 08,2024

Researchers pinpoint nongenetic mechanisms in lung cancer resistance to one commonly used therapy

by Katie Neith,City of Hope National Medical CenterCredit: Unsplash/CC0 Public DomainIn a recent study led by Ravi Salgia, M.D., Ph.D., the Arthur & Rosalie Kaplan Chair in Medical Oncology,

Updated on: June 01,2024

Researchers pinpoint nongenetic mechanisms in lung cancer resistance to one commonly used therapy

by Katie Neith,City of Hope National Medical CenterCredit: Unsplash/CC0 Public DomainIn a recent study led by Ravi Salgia, M.D., Ph.D., the Arthur & Rosalie Kaplan Chair in Medical Oncology,

Updated on:June 01,2024

New anti-cancer 'degrader' targets protein essential to infant leukemia

byVan Andel Research InstituteDiscovery of a first-in-class, highly potent VHL-recruiting ENL PROTAC degrader, MS41. Credit:Science Advances(2024). DOI: 10.1126/sciadv.ado1432Scienti

Updated on: September 10,2024

New anti-cancer 'degrader' targets protein essential to infant leukemia

byVan Andel Research InstituteDiscovery of a first-in-class, highly potent VHL-recruiting ENL PROTAC degrader, MS41. Credit:Science Advances(2024). DOI: 10.1126/sciadv.ado1432Scienti

Updated on:September 10,2024